Xeris Biopharma Holdings Overview
Xeris Biopharma Holdings Discounted Cash Flow
DCF Analysis for XERS.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.89
Current Fair Value
$2.89
↓ 58.4% Downside
Overvalued by 58.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison